ADYX — Adynxx Cashflow Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $8.41m
- $2.22m
Annual cashflow statement for Adynxx, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2014 December 31st | R2015 December 31st | C2016 December 31st | 2017 December 31st | 2018 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -25.4 | -26 | -28.2 | -25.7 | -8.42 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 10.9 | 5.79 | 3.91 | 11.3 | -2.42 |
| Unusual Items | |||||
| Purchased R&D | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.138 | -2.54 | 2.55 | -0.908 | -0.749 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -13.3 | -21.6 | -18.3 | -10.7 | -9.71 |
| Capital Expenditures | -0.34 | -0.423 | -0.893 | -0.179 | 0 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -2 | -14.9 | 3.1 | 4.06 | 29.3 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -2.34 | -15.4 | 2.21 | 3.88 | 29.3 |
| Financing Cash Flow Items | -0.669 | -0.471 | -2.63 | -0.84 | -0.002 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 20.3 | 46.3 | -4.38 | 3.39 | -12.9 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 4.67 | 9.31 | -20.5 | -3.4 | 6.7 |